Literature DB >> 24022130

Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines.

Yasuhiro Kodera, Kazumasa Fujitani, Norimasa Fukushima, Seiji Ito, Kei Muro, Norifumi Ohashi, Takaki Yoshikawa, Daisuke Kobayashi, Chie Tanaka, Michitaka Fujiwara.   

Abstract

Liver metastases from gastric cancer are rarely indicated for surgery because they are often diagnosed as multiple nodules occupying both lobes and coexist with extra hepatic disease. A literature search identified no clinical trials on hepatectomy for this disease; only retrospective studies of a relatively small number of cases collected over more than a decade, mostly from a single institution, were found. Five-year survival rates from these reports ranged from 0 % to 37 %, and long-term survivors were observed among carefully selected case series. The most commonly reported prognostic factor was the number of metastatic nodules, and patients with a solitary metastasis tended to have superior outcome. Patients diagnosed to have a small number of metastatic nodules by modern imaging tools could be indicated for surgery. Because both intrahepatic and extrahepatic recurrences are common,patients are likely to benefit from perioperative adjuvant chemotherapy, although it is not possible at this time to specify which regimen is the most appropriate

Entities:  

Mesh:

Year:  2014        PMID: 24022130     DOI: 10.1007/s10120-013-0299-x

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  42 in total

1.  Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Haruyuki Takaki; Yasuhiro Mori; Hitoshi Tonouchi; Masato Kusunoki; Hideya Kida; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2005-12       Impact factor: 3.464

2.  Japanese gastric cancer treatment guidelines 2010 (ver. 3).

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

3.  Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.

Authors:  T Kumada; Y Arai; K Itoh; Y Takayasu; K Nakamura; Y Ariyoshi; K Tajima
Journal:  Oncology       Date:  1999-10       Impact factor: 2.935

4.  Benefits and limits of hepatic resection for gastric metastases.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; H Yoshidome; Y Shimizu; N Nakajima
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

5.  Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection.

Authors:  Ken Shirabe; Mitsuo Shimada; Takashi Matsumata; Hidefumi Higashi; Yohichi Yakeishi; Shigeki Wakiyama; Yasuharu Ikeda; Takuhiro Ezaki; Shingo Fukuzawa; Kenji Takenaka; Keishi Kishikawa; Tetsuo Ikeda; Ken-ichi Taguchi; Yoshihiko Maehara; Keizo Sugimachi
Journal:  Hepatogastroenterology       Date:  2003 Sep-Oct

6.  The role of hepatectomy for patients with liver metastases of gastric cancer.

Authors:  Zenichi Morise; Atsushi Sugioka; Sojun Hoshimoto; Takazumi Kato; Masahiro Ikeda; Ichiro Uyama; Akihiko Horiguchi; Shuichi Miyakawa
Journal:  Hepatogastroenterology       Date:  2008 Jul-Aug

7.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

8.  Does anatomic versus nonanatomic resection affect recurrence and survival in patients undergoing surgery for colorectal liver metastasis?

Authors:  Umut Sarpel; Anthony S Bonavia; Alexis Grucela; Sasan Roayaie; Myron E Schwartz; Daniel M Labow
Journal:  Ann Surg Oncol       Date:  2008-11-20       Impact factor: 5.344

9.  Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002).

Authors:  Hiroyuki Narahara; Hiroyasu Iishi; Hiroshi Imamura; Akira Tsuburaya; Keisho Chin; Haruhiko Imamoto; Taito Esaki; Hiroshi Furukawa; Chikuma Hamada; Yuh Sakata
Journal:  Gastric Cancer       Date:  2011-02-23       Impact factor: 7.370

10.  What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis : imaging for recurrent colorectal cancer.

Authors:  Monique Maas; Iris J G Rutten; Patty J Nelemans; Doenja M J Lambregts; Vincent C Cappendijk; Geerard L Beets; Regina G H Beets-Tan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-06       Impact factor: 9.236

View more
  43 in total

Review 1.  Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?

Authors:  Yasuhiro Kodera; Daisuke Kobayashi; Chie Tanaka; Michitaka Fujiwara
Journal:  Surg Today       Date:  2014-11-01       Impact factor: 2.549

2.  Postoperative follow-up programs improve survival in curatively resected gastric and junctional cancer patients: a propensity score matched analysis.

Authors:  Leila Sisic; Moritz J Strowitzki; Susanne Blank; Henrik Nienhueser; Sara Dorr; Georg Martin Haag; Dirk Jäger; Katja Ott; Markus W Büchler; Alexis Ulrich; Thomas Schmidt
Journal:  Gastric Cancer       Date:  2017-07-24       Impact factor: 7.370

3.  Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.

Authors:  Lin Guo; Jin-Lei Ou; Tong Zhang; Liang Ma; Long-Fei Qu
Journal:  Tumour Biol       Date:  2015-06-12

4.  Hepatectomy Offers Superior Survival Compared with Non-surgical Treatment for ≤ 3 Metastatic Tumors with Diameters < 3 cm from Gastric Cancer: A Retrospective Study.

Authors:  Yu Ohkura; Hisashi Shinohara; Shusuke Haruta; Masaki Ueno; Masaji Hashimoto; Yoshiharu Sakai; Harushi Udagawa
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

5.  Systemic chemotherapy as a main strategy for liver metastases from gastric cancer.

Authors:  W Zhang; Y Yu; Y Fang; Y Wang; Y Cui; K Shen; T Liu
Journal:  Clin Transl Oncol       Date:  2015-06-25       Impact factor: 3.405

6.  Long-Term Outcomes in Laparoscopic D2 Gastrectomy for Gastric Cancer: a Large Comprehensive Study Proposing Novel Hypotheses.

Authors:  Lei Huang; Hao Liu; Jiang Yu; Tian Lin; Yan-Feng Hu; Tuan-Jie Li; Guo-Xin Li
Journal:  J Gastrointest Surg       Date:  2018-11-26       Impact factor: 3.452

Review 7.  Intensified neoadjuvant multimodal approach in synchronous liver metastases from gastric cancer: a single institutional experience.

Authors:  L Ceniceros; A Chopitea; F Pardo; F Rotellar; L Arbea; J J Sola; J C Subtil; B Sangro; A Benito; J L Hernández-Lizoain; J Rodríguez
Journal:  Clin Transl Oncol       Date:  2017-10-17       Impact factor: 3.405

Review 8.  The role of surgery in the therapeutic approach of gastric cancer liver metastases.

Authors:  Aikaterini Mastoraki; Christina Benetou; Sotiria Mastoraki; Ioannis S Papanikolaou; Nikolaos Danias; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  Indian J Gastroenterol       Date:  2016-08-16

9.  Surgical resection of hepatic metastases from gastric cancer: outcomes from national series in England.

Authors:  Sheraz R Markar; Hugh Mackenzie; Sameh Mikhail; Muntzer Mughal; Shaun R Preston; Nick D Maynard; Omar Faiz; George B Hanna
Journal:  Gastric Cancer       Date:  2016-03-03       Impact factor: 7.370

10.  Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.

Authors:  Ali Guner; Taeil Son; In Cho; In Gyu Kwon; Ji Yeong An; Hyoung-Il Kim; Jae-Ho Cheong; Sung Hoon Noh; Woo Jin Hyung
Journal:  Gastric Cancer       Date:  2015-08-01       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.